Abstract
Cancer remains the second leading cause of death worldwide even though advances in early diagnosis and treatment are being actively pursued. Nanoparticles (NPs) are one of the most widely studied materials in the recent decade and are emerging as promising agents in the cancer management. Pertinent to realizing this truth, toxicity issues related to nanoproducts are of particular concern that is often ignored. Nanostructures synthesised using materials of biological origin using eco-friendly ‘green’ chemistry approach, partially addresses this problem. Biologically synthesised NPs are accounted for various applications in cancer management such as bioimaging, drug delivery, sensitising, photothermal and photodynamic therapy and so on. Cancer stem cells (CSCs) are a small population of extremely tumourigenic and intrinsically drug resistant cells that are responsible for the tumour initiation, progression, resistance, and relapse. In addition to small molecules and nucleic acid-based therapeutics, combining nanomaterials with antibodies against CSC-specific markers or CSC-targeting agents have been engaged for the selective targeting and developing of anti-CSCs therapeutics. Yet despite the benefits reaped by the NPs, in the overall management of complex diseases like cancer, disadvantages such as toxicity and pollution inevitably follow. The first part of this review essentially budges on the application of NPs produced using ‘green’ biological materials, which are poised to dissipate some of the issues. The latter half is aimed to discuss the utility of nanoparticles in CSC-targeted therapies.
Keywords: Cancer stem cells, green chemistry, nanoparticles, nanomedicine, targeted therapy.
Graphical Abstract
Current Nanoscience
Title:Bridging ‘Green’ with Nanoparticles: Biosynthesis Approaches for Cancer Management and Targeting of Cancer Stem Cells
Volume: 12 Issue: 1
Author(s): Manu M. Joseph, Suraj K. George and T. T. Sreelekha
Affiliation:
Keywords: Cancer stem cells, green chemistry, nanoparticles, nanomedicine, targeted therapy.
Abstract: Cancer remains the second leading cause of death worldwide even though advances in early diagnosis and treatment are being actively pursued. Nanoparticles (NPs) are one of the most widely studied materials in the recent decade and are emerging as promising agents in the cancer management. Pertinent to realizing this truth, toxicity issues related to nanoproducts are of particular concern that is often ignored. Nanostructures synthesised using materials of biological origin using eco-friendly ‘green’ chemistry approach, partially addresses this problem. Biologically synthesised NPs are accounted for various applications in cancer management such as bioimaging, drug delivery, sensitising, photothermal and photodynamic therapy and so on. Cancer stem cells (CSCs) are a small population of extremely tumourigenic and intrinsically drug resistant cells that are responsible for the tumour initiation, progression, resistance, and relapse. In addition to small molecules and nucleic acid-based therapeutics, combining nanomaterials with antibodies against CSC-specific markers or CSC-targeting agents have been engaged for the selective targeting and developing of anti-CSCs therapeutics. Yet despite the benefits reaped by the NPs, in the overall management of complex diseases like cancer, disadvantages such as toxicity and pollution inevitably follow. The first part of this review essentially budges on the application of NPs produced using ‘green’ biological materials, which are poised to dissipate some of the issues. The latter half is aimed to discuss the utility of nanoparticles in CSC-targeted therapies.
Export Options
About this article
Cite this article as:
Joseph M. Manu, George K. Suraj and Sreelekha T. T., Bridging ‘Green’ with Nanoparticles: Biosynthesis Approaches for Cancer Management and Targeting of Cancer Stem Cells, Current Nanoscience 2016; 12 (1) . https://dx.doi.org/10.2174/1573413711666150624170401
DOI https://dx.doi.org/10.2174/1573413711666150624170401 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Small Molecular Probes for the Molecular Imaging of Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Lupus Nephritis: A Treatment Update
Current Clinical Pharmacology A Review of the Relationships Between Endogenous Sex Steroids and Incident Ischemic Stroke and Coronary Heart Disease Events
Current Cardiology Reviews Pharmacogenetics of Colon Cancer and Potential Implications for 5- Fluorouracil-Based Chemotherapy
Current Pharmacogenomics Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine
Mini-Reviews in Medicinal Chemistry Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers
Current Drug Metabolism Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior
Current Drug Delivery Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management
Current Medicinal Chemistry Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Recent Patents on DNA & Gene Sequences Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Current Drug Metabolism The Interaction of Titanocene Y with Double-Stranded DNA: A Computational Study
Letters in Drug Design & Discovery Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Current Aging Science Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets Green Reduction of Graphene Oxide into Graphene by Cow Urine
Current Nanomaterials Qualitative and Quantitative Variables that Affect the Potency of Fc- Mediated Effector Function In Vitro and In Vivo: Considerations for Passive Immunization Using Non-Neutralizing Antibodies
Current HIV Research Anticancer Activity of the Bioreductive and Non-Bioreductive Zerumbone Derivatives
Letters in Drug Design & Discovery Enhancing Nucleic Acid Delivery, Insights from the Cationic Phospholipid Carriers
Current Pharmaceutical Biotechnology